TABLE 1.

Clinical data for ovarian cancer TMA

Patient	Histologic subtype	Stage	Grade	DFS (mo)	OS (mo)	Patient status	Ascites
1	Serous	IV	3	17.5	20.7	Deceased	No
2	Serous	III	2	13.7	32.3	Deceased	No
3	Squamous	III	3	9.5	-	-	Yes
4	Transitional cell	III	3	26.6	162.3	Alive	Yes
5	Serous	III	3	8.3	12	Deceased	No
6	High grade serous	III	3	53.3	63.5	Deceased	No
7	Serous and endometrioid	III	2	39.8	43.1	Deceased	No
8	Serous	III	2	14.3	-	-	Yes
9	Serous	IV	3	16.5	18.8	Deceased	Yes
10	Serous	IV	3	12.7	43.7	Deceased	Yes
11	Serous	III	3	10.5	14.5	Deceased	No
12	Serous	III	3	14	31.5	Deceased	Yes
13	Serous	III	3	34	-	-	Yes
14	Serous	IV	3	12.2	31.6	Deceased	Yes
15	Serous	III	3	34.8	64.4	Deceased	Yes
16	Serous	III	3	24.3	146.7	Deceased	Yes
17	Serous	IV	3	12.8	15.8	Deceased	Yes
18	Serous	IV	3	9.5	12.5	Deceased	Yes
19	Serous	III	3	16.5	56.7	Deceased	No
20	Serous	IV	3	12	13	Deceased	Yes
21	Serous	IV	2	38.1	50	Deceased	Yes
22	Endometroid	III	3	45.1	79.6	Deceased	Yes
23	Serous	IV	3	11.4	-	-	Yes
24	Serous	IV	1	21.9	100.7	Deceased	Yes
25	Serous	III	3	23.1	53.8	Deceased	No
26	Endometrioid and clear cell	IV	3	5.3	16.9	Deceased	No

DFS, interval between the date of diagnosis and the date of recurrence; OS, interval between the date of surgery to last follow-up or death.